Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Vaccination of non-human primates against malignant lymphoma

Abstract

HERPESVIRUSES are the most important candidates for human cancer agents. The Epstein–Barr virus (EBV) in particular is suspected of being the causal agent in Burkitt's lymphoma and nasopharyngeal carcinoma1. Immunological principles, well understood from vaccine prophylaxis of viral diseases, provide the potential for the eventual control of herpesvirus-induced neoplasia. The development of safe and efficient cancer vaccines with the human candidate herpesviruses is, however, difficult, as there are no reliable in vitro or experimental animal methods for detecting oncogenic potential in preparations which might be applicable to the human subject. We are studying the problems of herpesvirus cancer vaccines in non-human primates. Two members of the herpesvirus family, H. saimiri (HVS) and H. ateles (HVA), induce malignant lymphoma and leukemia in several New World monkey species2,3. HVS-induced lymphoma in cotton topped (CT) marmoset monkeys (Saguinus oedipus) has been used in this study as all monkeys inoculated with HVS regularly develop malignant lymphoma within two months4,5. This investigation describes the effect of a killed herpesvirus cancer vaccine in protecting non-human primates against malignant lymphoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Klein, G., in The Herpesviruses (edit. by Kaplan, A. S.), 521–555 (Academic Press, New York and London 1973).

    Google Scholar 

  2. Meléndez, L. V., Hunt, R. D., Daniel, M. D., Blake, B. J., and Garcia, F. G., Science, 171, 1161–1163 (1971).

    Article  ADS  Google Scholar 

  3. Laufs, R., and Meléndez, L. V., J. natn. Cancer Inst., 51, 599–608 (1973).

    CAS  Google Scholar 

  4. Wolfe, L. G., Falk, L. A., and Deinhardt, F., J. natn. Cancer Inst., 47, 1145–1162 (1971).

    CAS  Google Scholar 

  5. Laufs, R., and Fleckenstein, B., Med. Microbiol. Immun., 158, 227–236 (1973).

    Article  CAS  Google Scholar 

  6. Laufs, R., Nature, 249, 571–572 (1974).

    Article  ADS  CAS  Google Scholar 

  7. Lennette, E. H., and Schmidt, N. J., Diagnostic Procedures for Viral and Rickettsial Diseases (American Public Health Association, New York, 1964).

    Google Scholar 

  8. Laufs, R., and Meléndez, L. V., Med. Microbiol. Immun., 158, 299–308 (1973).

    Article  CAS  Google Scholar 

  9. Shope, T., Dechairo, D., and Miller, G., Proc. natn. Acad. Sci. U. S. A., 70, 2487–2491 (1973).

    Article  ADS  CAS  Google Scholar 

  10. Epstein, M. A., Hunt, R. D., and Rabin, H., Int. J. Cancer, 12, 309–318 (1973).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LAUFS, R., STEINKE, H. Vaccination of non-human primates against malignant lymphoma. Nature 253, 71–72 (1975). https://doi.org/10.1038/253071a0

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1038/253071a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing